** Shares of Eurofins Scientific EUFI.PA falls over 9%
after the company reports nine-month growth below its guidance,
hitting the bottom of STOXX .STOXX index
** The group's nine-month organic sales growth of 5.2% on a
reported basis places it below its mid-term guidance of 6.5%,
analyst Sarah Thirion from Midcap Partners said in a note
** "The market is not buying" that their 2027 ambitions are
achievable, she added
** The company slightly trimmed its FY revenue guidance,
expecting it to be close to 7 billion euros versus a range of
7.075 billion to 7.175 billion euros previously
** The shares have now dropped by 18.7% year-to-date,
including today's decline
(Reporting by Leo Marchandon)
((Leo.marchandon@thomsonreuters.com))